DEA eases requirements for natural cannabis-derived drug research
December 23, 2015 at 12:14 PM EST
Dec 23 (Reuters) - The U.S Drug Enforcement Administration (DEA) on Wednesday relaxed some restrictions on research evaluating cannabidiol, an extract of the marijuana plant, for medicinal use.
